JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.

MLA

Xie, Li, et al. “JCAD Deficiency Attenuates Activation of Hepatic Stellate Cells and Cholestatic Fibrosis.” Clinical and Molecular Hepatology, vol. 30, no. 2, Apr. 2024, pp. 206–24. EBSCOhost, https://doi.org/10.3350/cmh.2023.0506.

APA

Xie, L., Chen, H., Zhang, L., Ma, Y., Zhou, Y., Yang, Y.-Y., Liu, C., Wang, Y.-L., Yan, Y.-J., Ding, J., Teng, X., Yang, Q., Liu, X.-P., & Wu, J. (2024). JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis. Clinical and Molecular Hepatology, 30(2), 206–224. https://doi.org/10.3350/cmh.2023.0506

Chicago

Xie, Li, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, et al. 2024. “JCAD Deficiency Attenuates Activation of Hepatic Stellate Cells and Cholestatic Fibrosis.” Clinical and Molecular Hepatology 30 (2): 206–24. doi:10.3350/cmh.2023.0506.